Inovio Pharma (INO)

Jan 9, 2025, 8:04 AM EST - 8 days ago

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

Jan 6, 2025, 7:19 AM EST - 11 days ago

Top 3 Health Care Stocks That Could Blast Off This Month

OTLK RCKT

Dec 13, 2024, 2:10 PM EST - 5 weeks ago

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

Dec 13, 2024, 7:00 AM EST - 5 weeks ago

INOVIO Announces Pricing of $30 Million Public Offering

Dec 12, 2024, 4:01 PM EST - 5 weeks ago

INOVIO Announces Proposed Public Offering

Dec 3, 2024, 8:00 AM EST - 6 weeks ago

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

Nov 29, 2024, 4:02 PM EST - 7 weeks ago

INOVIO Reports Inducement Grant Under Inducement Plan

Nov 15, 2024, 11:21 AM EST - 2 months ago

European And US Vaccine Stocks Are Under Pressure - Here's WHy

AZN BNTX GSK MRK SNY VALN

Nov 14, 2024, 7:53 PM EST - 2 months ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:05 PM EST - 2 months ago

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 13, 2024, 8:00 AM EST - 2 months ago

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

Nov 6, 2024, 4:05 PM EST - 2 months ago

INOVIO to Present at Upcoming Scientific Conferences

Nov 6, 2024, 8:00 AM EST - 2 months ago

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 21, 2024, 8:00 AM EDT - 3 months ago

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Oct 2, 2024, 4:15 PM EDT - 3 months ago

INOVIO Reports Inducement Grants Under Inducement Plan

Sep 17, 2024, 4:30 PM EDT - 4 months ago

INOVIO to Present at Upcoming Scientific Conference

Aug 9, 2024, 3:32 AM EDT - 5 months ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 5 months ago

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Jul 25, 2024, 4:05 PM EDT - 6 months ago

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Jul 25, 2024, 8:00 AM EDT - 6 months ago

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

Jul 11, 2024, 8:00 AM EDT - 6 months ago

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

Jul 2, 2024, 4:05 PM EDT - 7 months ago

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

Jul 1, 2024, 8:00 AM EDT - 7 months ago

INOVIO Added to Russell 2000® Index Effective July 1, 2024

Jun 4, 2024, 8:00 AM EDT - 8 months ago

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

May 20, 2024, 4:31 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)

May 15, 2024, 2:15 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)

May 14, 2024, 4:44 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)

May 13, 2024, 7:47 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 8 months ago

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights

Apr 29, 2024, 8:00 AM EDT - 9 months ago

INOVIO to Participate in Upcoming Investor Conferences in May

Apr 29, 2024, 8:00 AM EDT - 9 months ago

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024

Apr 15, 2024, 6:39 PM EDT - 9 months ago

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Mar 26, 2024, 6:28 PM EDT - 10 months ago

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

Mar 6, 2024, 8:25 PM EST - 11 months ago

Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 4:05 PM EST - 11 months ago

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Feb 21, 2024, 8:00 AM EST - 11 months ago

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

Feb 14, 2024, 4:02 PM EST - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference Transcript

Feb 7, 2024, 11:46 AM EST - 1 year ago

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 23, 2024, 8:00 AM EST - 1 year ago

INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split

Jan 22, 2024, 8:00 AM EST - 1 year ago

INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader

Jan 4, 2024, 8:00 AM EST - 1 year ago

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

CHRS

Jan 3, 2024, 8:00 AM EST - 1 year ago

INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program

Nov 9, 2023, 7:15 PM EST - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights

Oct 26, 2023, 8:00 AM EDT - 1 year ago

INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023

Oct 10, 2023, 8:00 AM EDT - 1 year ago

INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program

Sep 12, 2023, 6:09 PM EDT - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 25th Annual Global Investment Conference (Transcript)

Sep 7, 2023, 8:00 AM EDT - 1 year ago

INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis

Aug 29, 2023, 8:00 AM EDT - 1 year ago

INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 9, 2023, 6:40 PM EDT - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2023 Earnings Call Transcript